Results 91 to 100 of about 22,180 (202)

Differential Responsiveness to Exercise and Cognitive Remediation in Physical Health in People With Schizophrenia: Results From the CORTEX‐SP Study

European Journal of Sport Science, Volume 26, Issue 6, June 2026.
ABSTRACT Non‐pharmacological interventions, such as exercise and cognitive remediation, have been widely investigated in people with schizophrenia (SZ), showing beneficial effects and supporting their role as complementary approaches to pharmacological treatment.
Mikel Tous‐Espelosin, Nagore Iriarte‐Yoller, Agurne Sampedro, Iker Lasa‐Sagaseta, Cristóbal Pavon, Natalia Ojeda, Pedro Sanchez, Javier Peña, Sara Maldonado‐Martín   +8 more
wiley   +1 more source

The Spectrum of Abnormal Tongue Movements: Review of Phenomenology, Etiology, and Differential Diagnosis

Movement Disorders Clinical Practice, Volume 13, Issue 6, Page 1383-1398, June 2026.
ABSTRACT Background Classifying abnormal tongue movements is challenging due to their varied presentations and limited visibility compared to other body parts. Accurate identification of the phenomenology guides physical examination and can point to specific diagnoses.
Nathaniel Bendahan, Seyed‐Mohammad Fereshtehnejad, Christos Ganos, Emily Swinkin, Anthony E. Lang   +4 more
wiley   +1 more source

Social and Clinical Factors Associated With Antipsychotic Medication Discontinuation in Patients With Schizophrenia

International Journal of Methods in Psychiatric Research, Volume 35, Issue 2, June 2026.
ABSTRACT Objectives This study aims to identify social and clinical factors associated with antipsychotic medication discontinuation in patients with schizophrenia. Methods This cross‐sectional case‐control study comprised 111 schizophrenia patients, including 55 who discontinued medication on their own initiative and 56 matched continuous‐treatment ...
Zhengquan Chen, Yiming Wu, Zuowei Wang, Jun Wang, Chao Jiang, Wenchao Shen, Yanting Zheng, Yi Wu   +7 more
wiley   +1 more source

Aripiprazole

GALENICAL : Jurnal Kedokteran dan Kesehatan Mahasiswa Malikussaleh
Aripiprazole adalah obat antipsikotik generasi kedua yang biasa digunakan untuk mengobati skizofrenia. Aripiprazole dikenal sebagai "penstabil sistem dopamin" dengan mekanisme aksi yang memberikan agonisme parsial dengan afinitas tinggi pada dopamin D2 dan serotonin-5-HT1A reseptor serta antagonisme pada serotonin-5-HT2A reseptor dan menunjukkan bukti ...
Bela Nurfitri Erida, Suzanna Octiva
openaire   +1 more source

Associations Between Serum Adipokine, Antipsychotic Exposure, and Clinical Characteristics in Chronic Schizophrenia: A Cross‐Sectional Study

Neuropsychopharmacology Reports, Volume 46, Issue 2, June 2026.
In chronic schizophrenia, serum adiponectin levels were positively associated with antipsychotic dosage, particularly with multi‐acting receptor‐targeted antipsychotics and were influenced by gender and hospitalization period. These findings highlight gender‐specific metabolic regulation and the importance of monitoring adipokines during long‐term ...
Yasuhiro Ohno, Kiyomi Saito, Keita Hanabusa, Ayaka Nakai, Tomoko Nagai, Noriko Hida, Kenji Sanada   +6 more
wiley   +1 more source

A retrospective study of predictive factors for effective aripiprazole augmentation of antidepressant therapy in treatment-resistant depression

Neuropsychiatric Disease and Treatment, 2016
Hiroko Sugawara,1,2 Kaoru Sakamoto,1 Tsuyoto Harada,3 Satoru Shimizu,4 Jun Ishigooka1 1Department of Psychiatry, Tokyo Women’s Medical University, 2Support Center for Women Health Care Professionals and Researchers, Tokyo Women’s ...
Sugawara H, Sakamoto K, Harada T, Shimizu S, Ishigooka J   +4 more
doaj  

Solubility Behaviour of Aripiprazole in Different Solvent Systems

RGUHS Journal of Pharmaceutical Sciences
Background This current research work discusses the Aripiprazolersquos solubility behaviour in individual solvents and solvent blends to offer some theoretical foundation for the formulation scientists regarding solute solvent ...
Sharda Sambhakar, Shwetha S Kamath K, Thimmasetty J, Shashank Nayak N, Bishambar Singh, Paramita Das   +5 more
doaj   +1 more source

Pharmacological Management, Safety, and Outcomes in Bipolar Disorder: An Integrated Narrative Review of Clinical and Translational Evidence

Neuropsychopharmacology Reports, Volume 46, Issue 2, June 2026.
This graph summarizes bipolar disorder management, showing pharmacological treatments including lithium, valproate, antipsychotics, combination therapy, and emerging agents. It links these treatments to outcomes such as relapse reduction, mortality benefits, and cognitive effects, while highlighting safety issues, poor adherence, pregnancy risks, and ...
Gudisa Bereda
wiley   +1 more source

Changes in White Blood Cell and Neutrophil Counts in Patients With Schizophrenia Treated With Lithium Carbonate, Adenine, and Ninjin‐Yoei‐To: A Preliminary Study

Neuropsychopharmacology Reports, Volume 46, Issue 2, June 2026.
Thirty‐five patients with schizophrenia who received adenine, Ninjin‐yoei‐to, or lithium carbonate were included in the treatment group. Eighty‐one patients with schizophrenia comprised the control group. In the two‐way mixed ANOVA, treatment increased white blood cell and neutrophil counts in patients with schizophrenia, particularly from 2 months ...
Teruyuki Matsuoka, Sumihiro Yamano
wiley   +1 more source

Association of Preoperative Depression and Clinical Outcomes After Head and Neck Free Flap Reconstruction

Otolaryngology–Head and Neck Surgery, Volume 174, Issue 6, Page 1476-1483, June 2026.
Abstract Objective Comorbid depression is a significant negative predictor of survival in patients with head and neck cancer (HNC). Prior studies have shown a prevalence of up to 40.1%; however, depression is often underdiagnosed in this patient population. Study Design Retrospective cohort. Setting Single‐institution database.
Sindhura Sridhar, Daniel P. Larson, Brooke B. Swain, Heezy Suh, Daniel R. S. Habib, Kelly Vittetoe, Donald Sengstack, Michael C. Topf, Melanie D. Hicks   +8 more
wiley   +1 more source